跳到正文
STAT News· Elaine Chen·· 6 天前AI 评分9

STAT+:最惠国政策促使药企重新考虑海外上市

STAT+: Most-favored nations policy makes drugmakers rethink launches abroad

AI 导读

美国最惠国药价政策正促使药企重新考虑在海外推出新药的计划。STAT+ 的这篇付费报道聚焦该政策对药企海外上市决策的影响,正文内容需订阅后才能阅读。

正文 · 原文

Biogen under investigation, lawsuits over off-label GLP-1 promotion, and more biotech news

pushpins and lines connecting the states on a US map for telehealth licensing
Adobe

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. Thanksgiving is approaching and I’ve yet to make an all-butter pie crust that doesn’t shrink. Any tips or suggestions appreciated!

A former Eli Lilly sales rep filed a lawsuit alleging that she was fired after complaining that the company promoted its Mounjaro diabetes drug as a weight loss treatment before receiving regulatory approval to do so.

STAT+ Exclusive Story

Already have an account? Log in

STAT+

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

  1. Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.

来源:STAT News · statnews.com